Premium
Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)
Author(s) -
Laribi Kamel,
Poulain Stéphanie,
Willems Lise,
Merabet Fatiha,
Le Calloch Ronan,
Eveillard Jean R.,
Herbaux Charles,
RoosWeil Damien,
Chaoui Driss,
Roussel Xavier,
Tricot Sabine,
Dupuis Jehan,
Dartigeas Caroline,
Bareau Benoit,
Bene Marie C.,
Baugier de Materre Alix,
Leblond Véronique
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15718
Subject(s) - bendamustine , medicine , rituximab , lymphoplasmacytic lymphoma , waldenstrom macroglobulinemia , macroglobulinemia , pediatrics , immunology , lymphoma , multiple myeloma